1. Home
  2. CHEK vs MOVE Comparison

CHEK vs MOVE Comparison

Compare CHEK & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • MOVE
  • Stock Information
  • Founded
  • CHEK 2004
  • MOVE 2018
  • Country
  • CHEK Israel
  • MOVE United States
  • Employees
  • CHEK N/A
  • MOVE N/A
  • Industry
  • CHEK Medical Electronics
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CHEK Health Care
  • MOVE Health Care
  • Exchange
  • CHEK Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • CHEK 4.5M
  • MOVE 4.7M
  • IPO Year
  • CHEK 2015
  • MOVE 2021
  • Fundamental
  • Price
  • CHEK $0.73
  • MOVE $0.72
  • Analyst Decision
  • CHEK
  • MOVE Buy
  • Analyst Count
  • CHEK 0
  • MOVE 1
  • Target Price
  • CHEK N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • CHEK 34.0K
  • MOVE 1.3M
  • Earning Date
  • CHEK 08-14-2025
  • MOVE 08-13-2025
  • Dividend Yield
  • CHEK N/A
  • MOVE N/A
  • EPS Growth
  • CHEK N/A
  • MOVE N/A
  • EPS
  • CHEK N/A
  • MOVE N/A
  • Revenue
  • CHEK N/A
  • MOVE $1,013,000.00
  • Revenue This Year
  • CHEK N/A
  • MOVE $1,460.71
  • Revenue Next Year
  • CHEK N/A
  • MOVE $96.77
  • P/E Ratio
  • CHEK N/A
  • MOVE N/A
  • Revenue Growth
  • CHEK N/A
  • MOVE N/A
  • 52 Week Low
  • CHEK $0.56
  • MOVE $0.51
  • 52 Week High
  • CHEK $3.04
  • MOVE $6.97
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 41.33
  • MOVE 51.11
  • Support Level
  • CHEK $0.73
  • MOVE $0.68
  • Resistance Level
  • CHEK $0.80
  • MOVE $0.79
  • Average True Range (ATR)
  • CHEK 0.02
  • MOVE 0.09
  • MACD
  • CHEK -0.00
  • MOVE 0.01
  • Stochastic Oscillator
  • CHEK 14.29
  • MOVE 71.06

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: